Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis
- 1 July 2018
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 60, 50-58
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Reliability of Basophil Activation Test Using CD203c Expression in Diagnosis of Pollen AllergyAmerican Journal of Rhinology & Allergy, 2011
- Mechanisms of allergen-specific immunotherapyJournal of Allergy and Clinical Immunology, 2011
- Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processesClinical & Experimental Allergy, 2010
- House dust mite allergens in asthma and allergyTrends in Molecular Medicine, 2010
- CD‐sens: a biological measure of immunological changes stimulated by ASITAllergy, 2009
- Flow‐assisted allergy diagnosis: current applications and future perspectivesAllergy, 2006
- Basophil allergen threshold sensitivity: a useful approach to anti‐IgE treatment efficacy evaluationAllergy, 2006
- TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligandJournal of Experimental Medicine, 2005
- The Basophil-Specific Ectoenzyme E-NPP3 (CD203c) as a Marker for Cell Activation and Allergy DiagnosisInternational Archives of Allergy and Immunology, 2004
- Inhibition of human allergic T-cell responses by IL-10–treated dendritic cells: Differences from hydrocortisone-treated dendritic cellsJournal of Allergy and Clinical Immunology, 2001